Art

J-GLOBAL ID：200902100458819889   Reference number：02A0956089

α₁-Adrenoceptor Activation: A Comparison of 4-(Anilinomethyl)imidazoles and 4-(Phenoxymethyl)imidazoles to Related 2-Imidazolines.

α₁-アドレナリン受容体活性化 4-(アニリノメチル)イミダゾール類及び4-(フェノキシメチル)イミダゾール類の関連2-イミダゾリン類との比較

Author (9)： HODSON S J (GlaxoSmithKline Res. and Dev., NC, USA) ,  BIGHAM E C (GlaxoSmithKline Res. and Dev., NC, USA) ,  GARRISON D T (GlaxoSmithKline Res. and Dev., NC, USA) ,  GOBEL M J (GlaxoSmithKline Res. and Dev., NC, USA) ,  IRVING P E (GlaxoSmithKline Res. and Dev., NC, USA) ,  LIACOS J A (GlaxoSmithKline Res. and Dev., NC, USA) ,  NAVAS F III (GlaxoSmithKline Res. and Dev., NC, USA) ,  SAUSSY D L JR (GlaxoSmithKline Res. and Dev., NC, USA) ,  BISHOP M J (GlaxoSmithKline Res. and Dev., NC, USA)
Material： Bioorganic & Medicinal Chemistry Letters  (Bioorg Med Chem Lett)
Volume： 12  Issue： 23  Page： 3449-3452  Publication year： Dec. 02, 2002 
JST Material Number： W0248A  ISSN： 0960-894X  Document type： Article
Article type： 短報  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *nitrogen heterocyclic compound ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0956089&from=J-GLOBAL&jstjournalNo=W0248A") }}

JST classification (2)： Imidazoles  (CF07083X) ,  Structure-activity relationship of drugs  (GV01050B)

Substance index (26)： N-(2-Imidazoline-2-ylmethyl)-2-(methylsulfonyl)-5-methoxyaniline ,  2-[2-(2-Imidazoline-2-ylmethoxy)phenyl]pyridine ,  2,5-Dimethylphenyl(2-imidazoline-2-ylmethyl) ether ,  N-(2-Imidazoline-2-ylmethyl)-2,5-dichloroaniline ,  N-(2-Imidazoline-2-ylmethyl)-2-(methylthio)aniline ,  N-(2-Imidazoline-2-ylmethyl)-2-(methylsulfonyl)aniline ,  N-(2-Imidazoline-2-ylmethyl)-2-(5-oxazolyl)aniline ,  N-Propyl-2-[(2-imidazoline-2-ylmethyl)amino]benzamide ,  N,N-Dipropyl-2-[(2-imidazoline-2-ylmethyl)amino]benzamide ,  N-(2-Imidazoline-2-ylmethyl)-2-piperidinoaniline ,  N-(3H-Imidazole-4-ylmethyl)-2-(methylthio)aniline ,  N-(3H-Imidazole-4-ylmethyl)-2-(methylsulfonyl)aniline ,  N-(3H-Imidazole-4-ylmethyl)-2-(5-oxazolyl)aniline ,  N-Propyl-2-[(3H-imidazole-4-ylmethyl)amino]benzamide ,  N,N-Dipropyl-2-[(3H-imidazole-4-ylmethyl)amino]benzamide ,  N-(3H-Imidazole-4-ylmethyl)-2-piperidinoaniline ,  2-(2-Biphenylyloxymethyl)-2-imidazoline ,  2-(5-Isoxazolyl)phenyl(2-imidazoline-2-ylmethyl) ether ,  N,N-Dipropyl-2-(2-imidazoline-2-ylmethoxy)benzamide ,  2-Biphenylyl(3H-imidazole-4-ylmethyl) ether ,  2-(5-Isoxazolyl)phenyl(3H-imidazole-4-ylmethyl) ether ,  N,N-Dipropyl-2-(3H-imidazole-4-ylmethoxy)benzamide ,  8-[(2-Imidazoline-2-ylmethyl)amino]-2-naphthol ,  8-[(3H-Imidazole-4-ylmethyl)amino]-2-naphthol ,  4-Chloromethylimidazole ,  1-Trityl-1H-imidazole-4-methanol

Terms in the title (4)： アドレナリン受容体 ,  活性化 ,  イミダゾール類 ,  2-イミダゾリン